[Drug-induced pneumopathies (excluding cytostatic drugs)].
Establishing the diagnosis of drug-induced pneumonitis is always difficult and requires that the following criteria be met: administration of the drug on a long-term basis; knowledge that the drug is able to induce pulmonary disorders; occurrence during therapy of interstitial pneumonitis with clinical, radiological and functional characteristics of this type of lung disease; exclusion of all other causes of interstitial pneumonitis (cardiac failure, infections, collagen vascular diseases, malignancies); bronchoalveolar lavage specimen, revealing lymphocytosis with an inverted CD4/CD8 lymphocyte ratio, isolated or associated with neutrophil and/or eosinophil alveolitis; finally, full recovery within several weeks or months after drug withdrawal unless irreversible pulmonary fibrosis has occurred. Certain specific characteristics correspond to the therapeutic class of the drug, i.e. antimicrobial, cardiovascular, antiinflammatory, neurological, metabolic, antiallergy or some other drugs.
Akoun
G
G
Centre de Pneumologie et de Reanimation Respiratoire, Hôpital Tenon, Paris.
Milleron
B
B
Mayaud
C
C
D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced* / Q000175:diagnosis / Q000628:therapy; D011658:Pulmonary Fibrosis / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy
Les pneumopathies médicamenteuses (cytostatiques exclus).